Okla. Stat. tit. 63, § 63-2-805: Approval – Termination date – Reporting – Rules

A. The State Commissioner of Health shall have the authority to

approve physicians conducting clinical trials performed pursuant to

the provisions of this act. In the event of a substantial violation

of this act, the Commissioner shall provide written notice to the

Oklahoma State Bureau of Narcotics and Dangerous Drugs Control and

the Governor. The Governor, upon receipt of a notice from the

Commissioner, shall have the authority to terminate the operations

of a clinical trial found to be in violation of any provision of

this act.

B. The clinical trials and related research authorized by this

act shall adhere to the highest standards of academic research

including, but not limited to, peer review of research conducted

pursuant to this act.

C. Clinical trials and related research authorized by this act

shall conclude no later than December 31, 2017. Nothing in this act

shall be construed as to permit the continuation of clinical trials

after December 31, 2017, without approval by a concurrent resolution

approved by the Legislature expressing approval of such

continuation.

D. The State Commissioner of Health shall submit a report to

the Chair and Vice Chair of the Senate Health and Human Services

Committee, the Chair and Vice Chair of the House Alcohol, Tobacco

and Dangerous Drugs Committee, and the Chair and Vice Chair of the

House Public Health Committee on or before December 31, 2017. Such

report shall include a summary of findings from clinical trials

authorized by this act. The Commissioner shall, upon request by the

Chair and Vice Chair of the Committees specified in this subsection,

make available any data, excluding individual health records,

relating to clinical trials authorized by this act.

E. The Oklahoma State Bureau of Narcotics and Dangerous Drugs

Control, the State Board of Health, and the Oklahoma State Regents

for Higher Education shall promulgate rules to implement the

provisions of this act.